Europe Heart Failure POC And LOC Devices Market Size, Share & Industry Trends Analysis Report By Test Type (Proteomic Testing, Metabolomic Testing, and Genomic Testing), By End Use, By Technology, By Country and Growth Forecast, 2023 - 2030

Europe Heart Failure POC And LOC Devices Market Size, Share & Industry Trends Analysis Report By Test Type (Proteomic Testing, Metabolomic Testing, and Genomic Testing), By End Use, By Technology, By Country and Growth Forecast, 2023 - 2030


The Europe Heart Failure POC And LOC Devices Market would witness market growth of 16.2% CAGR during the forecast period (2023-2030).

The integration of artificial intelligence in POC and LOC devices is a notable trend, enhancing diagnostic accuracy and predictive capabilities. AI algorithms analyze complex datasets generated by these devices, providing insights into disease progression and personalized treatment strategies. The improvement of telehealth and remote patient monitoring is influencing the development of POC and LOC devices that can be used outside traditional healthcare settings. These technologies enable patients to monitor their heart health at home, fostering early detection of deterioration and reducing hospital admissions.

Multiplexed assays on POC and LOC devices allow simultaneous measurement of multiple biomarkers, providing a comprehensive patient's cardiac status profile. This trend aligns with the need for a holistic understanding of heart failure and facilitates personalized treatment approaches. Collaborations between technology developers, pharmaceutical companies, and healthcare providers are becoming increasingly common. These partnerships desire to leverage the strengths of each stakeholder to accelerate the development and adoption of POC and LOC devices in heart failure management.

European countries' Governments and health agencies often support initiatives to improve healthcare outcomes. Funding support for research and development and initiatives focused on cardiovascular health. According to Eurostat, diseases of the circulatory system are the leading cause of death in the EU, responsible for almost one-third (32.7 %) of all deaths in 2020. Europe is experiencing a notable increase in the prevalence of circulatory system diseases, including heart failure. Demographic shifts, an aging population, and lifestyle changes contribute to the growing burden of cardiovascular conditions, necessitating advanced diagnostic tools. Therefore, the factors mentioned above will propel the market growth in this region.

The Germany market dominated the Europe Heart Failure POC And LOC Devices Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $16,864.5 Thousands by 2030. The UK market is exhibiting a CAGR of 15.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 17.1% during (2023 - 2030).

Based on Test Type, the market is segmented into Proteomic Testing, Metabolomic Testing, and Genomic Testing. Based on End Use, the market is segmented into Clinics, Hospitals, Laboratory, Assisted Living Healthcare Facilities, and Home. Based on Technology, the market is segmented into Microfluidics, Array-Based Systems, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Siemens Healthineers AG (Siemens AG), Danaher Corporation, F. Hoffmann-La Roche Ltd., BioMerieux S.A., QuidelOrtho Corporation, Trinity Biotech Plc, Jant Pharmacal Corporation, Abaxis, Inc. (Zoetis Services LLC) and Werfen, S.A.

Scope of the Study

Market Segments covered in the Report:

By Test Type
  • Proteomic Testing
  • Metabolomic Testing
  • Genomic Testing
By End Use
  • Clinics
  • Hospitals
  • Laboratory
  • Assisted Living Healthcare Facilities
  • Home
By Technology
  • Microfluidics
  • Array-Based Systems
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Abbott Laboratories
  • Siemens Healthineers AG (Siemens AG)
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • BioMerieux S.A.
  • QuidelOrtho Corporation
  • Trinity Biotech Plc
  • Jant Pharmacal Corporation
  • Abaxis, Inc. (Zoetis Services LLC)
  • Werfen, S.A.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Heart Failure POC And LOC Devices Market, by Test Type
1.4.2 Europe Heart Failure POC And LOC Devices Market, by End Use
1.4.3 Europe Heart Failure POC And LOC Devices Market, by Technology
1.4.4 Europe Heart Failure POC And LOC Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Heart Failure POC And LOC Devices Market by Test Type
4.1 Europe Proteomic Testing Market by Country
4.2 Europe Metabolomic Testing Market by Country
4.3 Europe Genomic Testing Market by Country
Chapter 5. Europe Heart Failure POC And LOC Devices Market by End Use
5.1 Europe Clinics Market by Country
5.2 Europe Hospitals Market by Country
5.3 Europe Laboratory Market by Country
5.4 Europe Assisted Living Healthcare Facilities Market by Country
5.5 Europe Home Market by Country
Chapter 6. Europe Heart Failure POC And LOC Devices Market by Technology
6.1 Europe Microfluidics Market by Country
6.2 Europe Array-Based Systems Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Heart Failure POC And LOC Devices Market by Country
7.1 Germany Heart Failure POC And LOC Devices Market
7.1.1 Germany Heart Failure POC And LOC Devices Market by Test Type
7.1.2 Germany Heart Failure POC And LOC Devices Market by End Use
7.1.3 Germany Heart Failure POC And LOC Devices Market by Technology
7.2 UK Heart Failure POC And LOC Devices Market
7.2.1 UK Heart Failure POC And LOC Devices Market by Test Type
7.2.2 UK Heart Failure POC And LOC Devices Market by End Use
7.2.3 UK Heart Failure POC And LOC Devices Market by Technology
7.3 France Heart Failure POC And LOC Devices Market
7.3.1 France Heart Failure POC And LOC Devices Market by Test Type
7.3.2 France Heart Failure POC And LOC Devices Market by End Use
7.3.3 France Heart Failure POC And LOC Devices Market by Technology
7.4 Russia Heart Failure POC And LOC Devices Market
7.4.1 Russia Heart Failure POC And LOC Devices Market by Test Type
7.4.2 Russia Heart Failure POC And LOC Devices Market by End Use
7.4.3 Russia Heart Failure POC And LOC Devices Market by Technology
7.5 Spain Heart Failure POC And LOC Devices Market
7.5.1 Spain Heart Failure POC And LOC Devices Market by Test Type
7.5.2 Spain Heart Failure POC And LOC Devices Market by End Use
7.5.3 Spain Heart Failure POC And LOC Devices Market by Technology
7.6 Italy Heart Failure POC And LOC Devices Market
7.6.1 Italy Heart Failure POC And LOC Devices Market by Test Type
7.6.2 Italy Heart Failure POC And LOC Devices Market by End Use
7.6.3 Italy Heart Failure POC And LOC Devices Market by Technology
7.7 Rest of Europe Heart Failure POC And LOC Devices Market
7.7.1 Rest of Europe Heart Failure POC And LOC Devices Market by Test Type
7.7.2 Rest of Europe Heart Failure POC And LOC Devices Market by End Use
7.7.3 Rest of Europe Heart Failure POC And LOC Devices Market by Technology
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Siemens Healthineers AG (Siemens AG)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Danaher Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 BioMerieux S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 QuidelOrtho Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.7 Trinity Biotech plc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Jant Pharmacal Corporation
8.8.1 Company Overview
8.9 Abaxis, Inc. (Zoetis Services LLC)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.10. Werfen, S.A.
8.10.1 Company Overview
8.10.2 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings